Clinical Trials & COVID-19

The OXD01-001
Study

What is the purpose of the OXD01-001 study?

The OXD01-001 study is a clinical trial for people with an opioid use disorder (OUD). The study is testing a digital therapy called MODIAᵀᴹ. MODIA is designed to give therapy and counseling that can be accessed using a mobile phone, tablet, or computer with internet.

Who can join the OXD01-001 study?

You may qualify for the OXD01-001 study if you meet the following requirements:

Other requirements will apply.

What will happen during the study?

If you qualify and decide to join the OXD01-001 study, your participation will last about 6 months (180 days). During this time, you will be asked to do the following:

  • Use MODIA 1–2 times a week for 15–30 minutes a day (if assigned).
  • You will be randomly assigned (like the flip of the coin) to receive access to MODIA or not.
  • If you do not receive access to MODIA during the study, you may be able to receive access after the study is complete.
    • Take opioid use disorder medication as instructed by the study staff.
    • Answer questions about your health.
    • Provide urine samples at weekly study visits.
    • Attend 25 scheduled study visits.